We are live on ! Find out more
ACM

Arlington Capital Management Portfolio holdings

AUM $161M
1-Year Est. Return 38.38%
This Fund
S&P 500
This Quarter Est. Return
+12.4%
1 Year Est. Return
+38.38%
3 Year Est. Return
+153.55%
5 Year Est. Return
+294.8%
10 Year Est. Return
+509.37%
AUM
$118M
AUM Growth
Cap. Flow
+$112M
Cap. Flow %
94.99%
Top 10 Hldgs %
76.1%
Holding
31
New
31
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 11.83%
2 Healthcare 10.63%
3 Industrials 9.07%
4 Communication Services 1.54%
5 Real Estate 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
26
Philip Morris
PM
$299B
$478K 0.4%
+5,867
New +$504K
T icon
27
AT&T
T
$159B
$462K 0.39%
+18,209
New +$472K
ATCO
28
DELISTED
Atlas Corp.
ATCO
$357K 0.3%
+19,796
New +$388K
AZN icon
29
AstraZeneca
AZN
$266B
$278K 0.24%
+3,953
New +$283K
EXC icon
30
Exelon
EXC
$46.6B
$219K 0.19%
+8,293
New +$213K
EMD
31
Western Asset Emerging Markets Debt Fund
EMD
$611M
$160K 0.14%
+10,155
New +$169K

Similar funds

Arlington Capital Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Arlington Capital Management, which disclosed 31 positions worth $118M. Its ten largest holdings account for 76% of the portfolio.

Its largest position is iShares Biotechnology ETF: 149,508 shares worth $15.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, followed by Healthcare and Industrials.

  • Arlington Capital Management's largest Q4 2014 buy was iShares Biotechnology ETF: 149,508 shares worth $15.1M.
  • Arlington Capital Management's ten largest holdings make up 76% of its $118M portfolio in Q4 2014.
  • Arlington Capital Management disclosed 31 positions in Q4 2014, its first 13F filing on record.

Based on Arlington Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.